The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol

Linda S Chesterton, Krysia S Dziedzic, Danielle A van der Windt, Graham Davenport, Helen L Myers, Trishna Rathod, Milica Blagojevic-Bucknall, Sue M Jowet, Claire Burton, Edward Roddy, Elaine M Hay, Linda S Chesterton, Krysia S Dziedzic, Danielle A van der Windt, Graham Davenport, Helen L Myers, Trishna Rathod, Milica Blagojevic-Bucknall, Sue M Jowet, Claire Burton, Edward Roddy, Elaine M Hay

Abstract

Background: Patients diagnosed with idiopathic mild to moderate carpal tunnel syndrome (CTS) are usually managed in primary care and commonly treated with night splints and/or corticosteroid injection. The comparative effectiveness of these interventions has not been reliably established nor investigated in the medium and long term. The primary objective of this trial is to investigate whether corticosteroid injection is effective in reducing symptoms and improving hand function in mild to moderate CTS over 6 weeks when compared with night splints. Secondary objectives are to determine specified comparative clinical outcomes and cost effectiveness of corticosteroid injection over 6 and 24 months.

Method/design: A multicentre, randomised, parallel group, clinical pragmatic trial will recruit 240 adults aged ≥18 years with mild to moderate CTS from GP Practices and Primary-Secondary Care Musculoskeletal Interface Clinics. Diagnosis will be by standardised clinical assessment. Participants will be randomised on an equal basis to receive either one injection of 20 mg Depo-Medrone or a night splint to be worn for 6 weeks. The primary outcome is the overall score of the Boston Carpal Tunnel Questionnaire (BCTQ) at 6 weeks. Secondary outcomes are the BCTQ symptom severity and function status subscales, symptom intensity, interrupted sleep, adherence to splinting, perceived benefit and satisfaction with treatment, work absence and reduction in work performance, EQ-5D-5L, referral to surgery and health utilisation costs. Participants will be assessed at baseline and followed up at 6 weeks, 6, 12 and 24 months. The primary analysis will use an intention to treat (ITT) approach and multiple imputation for missing data. The sample size was calculated to detect a 15 % greater improvement in the BTCQ overall score in the injection group compared to night-splinting at approximately 90 % power, 5 % two-tailed significance and allows for 15 % loss to follow-up.

Discussion: The trial makes an important contribution to the evidence base available to support effective conservative management of CTS in primary care. No previous trials have directly compared these treatments for CTS in primary care populations, reported on clinical effectiveness at more than 6 months nor compared cost effectiveness of the interventions.

Trial registration: Trial registration: EudraCT 2013-001435-48 (registered 05/06/2013), ClinicalTrials.gov NCT02038452 (registered 16/1/2014), and Current Controlled Trials ISRCTN09392969 (retrospectively registered 01/05/2014).

Keywords: Boston Carpal Tunnel Questionnaire; Carpal Tunnel Syndrome; Corticosteroid injection; Night splints; Protocol; Randomised clinical trial.

Figures

Fig. 1
Fig. 1
Flow of participants through the trial

References

    1. Phalen GS. The carpal-tunnel syndrome. Seventeen years’ experience in diagnosis and treatment of six hundred fifty-four hands. J Bone Joint Surg Am. 1966;48(2):211–28.
    1. Dziedzic K, Thomas E, Hill S, Wilkie R, Peat G, Croft PR. The impact of musculoskeletal hand problems in older adults: findings from the North Staffordshire Osteoarthritis Project (NorStOP) Rheumatology (Oxford) 2007;46(6):963–7. doi: 10.1093/rheumatology/kem005.
    1. Hill S, Dziedzic K, Thomas E, Baker SR, Croft P. The illness perceptions associated with health and behavioural outcomes in people with musculoskeletal hand problems: findings from the North Staffordshire Osteoarthritis Project (NorStOP) Rheumatology (Oxford) 2007;46(6):944–51. doi: 10.1093/rheumatology/kem015.
    1. Spies-Dorgelo MN, van der Windt DA, van der Horst HE, Prins AP, Stalman WA. Hand and wrist problems in general practice--patient characteristics and factors related to symptom severity. Rheumatology (Oxford) 2007;46(11):1723–8. doi: 10.1093/rheumatology/kem253.
    1. Bland JDP, Rudolfer SM. Clinical surveillance of carpal tunnel syndrome in two areas of the United Kingdom, 1991–2001. J Neurol Neurosurg Psychiatry. 2003;74(12):1674–9. doi: 10.1136/jnnp.74.12.1674.
    1. Werner RA, Andary M. Carpal tunnel syndrome: pathophysiology and clinical neurophysiology. Clin Neurophysiol. 2002;113(9):1373–81. doi: 10.1016/S1388-2457(02)00169-4.
    1. Alfonso C, Jann S, Massa R, Torreggiani A. Diagnosis, treatment and follow-up of the carpal tunnel syndrome: A review. Neurol Sci. 2010;31(3):243–52. doi: 10.1007/s10072-009-0213-9.
    1. D’Arcy CA, McGee S. The rational clinical examination. Does this patient have carpal tunnel syndrome? JAMA. 2000;283(23):3110–7. doi: 10.1001/jama.283.23.3110.
    1. Huisstede BM, Hoogvliet P, Randsdorp MS, Glerum S, van Middelkoop M, Koes BW. Carpal Tunnel Syndrome. Part I: Effectiveness of Nonsurgical Treatments–A Systematic Review. Arch Phys Med Rehabil. 2010;91(7):981–1004. doi: 10.1016/j.apmr.2010.03.022.
    1. Verdugo RJ, Salinas RA, Castillo JL, Cea JG. Surgical versus non-surgical treatment for carpal tunnel syndrome. Cochrane Database Syst Rev. 2008;4:CD001552-NaN.
    1. Bland JD. Treatment of carpal tunnel syndrome. Muscle Nerve. 2007;36(2):167–71. doi: 10.1002/mus.20802.
    1. Burton C, Chesterton LS, Davenport G. Diagnosing and managing carpal tunnel syndrome in primary care. Br J Gen Pract. 2014;64(622):262–3. doi: 10.3399/bjgp14X679903.
    1. O’Connor D, Marshall SC, Massy-Westropp N, Pitt V. Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome. Cochrane Database Syst Rev. 2003;1:CD003219-NaN.
    1. Page MJ, Massy-Westropp N, O’Connor D, Pitt V. Splinting for carpal tunnel syndrome. Cochrane Database Syst Rev. 2012;7:CD010003-NaN.
    1. Marshall SC, Tardif G, Ashworth NL. Local corticosteroid injection for carpal tunnel syndrome. Cochrane Database Syst Rev. 2007;2:CD001554-NaN.
    1. Dammers JW, Roos Y, Veering MM, Vermeulen M. Injection with methylprednisolone in patients with the carpal tunnel syndrome: a randomised double blind trial testing three different doses. J Neurol. 2006;253(5):574–7. doi: 10.1007/s00415-005-0062-2.
    1. Sevim S, Dogu O, Camdeviren H, Kaleagasi H, Aral M, Arslan E, Milcan A. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurol Sci. 2004;25(2):48–52. doi: 10.1007/s10072-004-0229-0.
    1. Ucan H, Yagci I, Yilmaz L, Yagmurlu F, Keskin D, Bodur H. Comparison of splinting, splinting plus local steroid injection and open carpal tunnel release outcomes in idiopathic carpal tunnel syndrome. Rheumatol Int. 2006;27(1):45–51. doi: 10.1007/s00296-006-0163-y.
    1. The British Society for Surgery of the Hand. BSSH Evidence for Surgical Treatment 1 Carpal Tunnel Syndrome. 2012. . Accessed 22 Oct 2012 2012.
    1. Weiss ND, Gordon L, Bloom T, So Y, Rempel DM. Position of the wrist associated with the lowest carpal-tunnel pressure: implications for splint design. J Bone Joint Surg (Am Vol) 1995;77(11):1695–9.
    1. Levine DW, Simmons BP, Koris MJ, Daltroy LH, Hohl GG, Fossel AH, Katz JN. A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. J Bone Joint Surg (Am Vol) 1993;75(11):1585–92.
    1. Atroshi I, Johnsson R, Sprinchorn A. Self-administered outcome instrument in carpal tunnel syndrome: reliability, validity and responsiveness evaluated in 102 patients. Acta Orthop Scand. 1998;69(1):82–9. doi: 10.3109/17453679809002363.
    1. Leite JC, Jerosch-Herold C, Song F. A systematic review of the psychometric properties of the Boston Carpal Tunnel Questionnaire. BMC Musculoskelet Disord. 2006;7:78. doi: 10.1186/1471-2474-7-78.
    1. Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol. 1988;41(4):313–21. doi: 10.1016/0895-4356(88)90138-2.
    1. Foster NE, Thomas E, Barlas P, Hill JC, Young J, Mason E, Hay EM. Acupuncture as an adjunct to exercise based physiotherapy for osteoarthritis of the knee: randomised controlled trial. BMJ. 2007
    1. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011;20(10):1727–36. doi: 10.1007/s11136-011-9903-x.
    1. NHS: Institute for Innovation and Improvement. Carpal Tunnel Syndrome (CTS) - The Map of Medicine. 2012. . Accessed 25 Oct 2012 2012.
    1. BMJ Group, Pharmaceutical Press. 10.1.2.2 Local Corticosteroid Injections. In: Anonymous British National Formulary. BMJ Group; Pharmaceutical Press; 2013.
    1. American Academy of Orthopaedic Surgeons . Clinical practice guideline on the diagnosis of carpal tunnel syndrome. 2007.
    1. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30(4):377–99. doi: 10.1002/sim.4067.
    1. Spies-Dorgelo MN, Terwee CB, Stalman WA, van der Windt DA. Reproducibility and responsiveness of the Symptom Severity Scale and the hand and finger function subscale of the Dutch arthritis impact measurement scales (Dutch-AIMS2-HFF) in primary care patients with wrist or hand problems. Health Qual Life Outcomes. 2006;4:87. doi: 10.1186/1477-7525-4-87.
    1. Atroshi I, Flondell M, Hofer M, Ranstam J. Methylprednisolone injections for the carpal tunnel syndrome: a randomized, placebo-controlled trial. Ann Intern Med. 2013;159:309–17. doi: 10.7326/0003-4819-159-5-201309030-00004.
    1. Peters-Veluthamaningal C, Winters JC, Groenier KH, Meyboom-de JB. Randomised controlled trial of local corticosteroid injections for carpal tunnel syndrome in general practice. BMC Fam Pract. 2010;11:54. doi: 10.1186/1471-2296-11-54.
    1. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal. 2013. .
    1. Curtis L, Burns A. Unit costs of health and social care. 2015.
    1. Department of Health. NHS reference costs.2015. .
    1. Office of National Statistics. Standard ocupational classifications. 2010. .
    1. Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med. 2000;19(23):3219–36. doi: 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>;2-P.
    1. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2005;14(5):487–96. doi: 10.1002/hec.944.
    1. Descatha A, Dale AM, Franzblau A, Coomes J, Evanoff B. Diagnostic strategies using physical examination are minimally useful in defining carpal tunnel syndrome in population-based research studies. Occup Environ Med. 2010;67(2):133–5. doi: 10.1136/oem.2009.047431.
    1. Graham B, Regehr G, Naglie G, Wright JG. Development and Validation of Diagnostic Criteria for Carpal Tunnel Syndrome. J Hand Surg. 2006;31(6):919.e1,919.e2,919.e3,919.e4,919.e5,919.e6,919.e7.
    1. El Miedany Y, Ashour S, Youssef S, Mehanna A, Meky FA. Clinical diagnosis of carpal tunnel syndrome: old tests-new concepts. Joint Bone Spine. 2008;75(4):451–7. doi: 10.1016/j.jbspin.2007.09.014.
    1. Kamath V, Stothard J. A clinical questionnaire for the diagnosis of carpal tunnel syndrome. J Hand Surg (Br) 2003;28(5):455–9. doi: 10.1016/S0266-7681(03)00151-7.
    1. Katz JN, Larson MG, Sabra A, Krarup C, Stirrat CR, Sethi R, Eaton HM, Fossel AH, Liang MH. The carpal tunnel syndrome: Diagnostic utility of the history and physical examination findings. Ann Intern Med. 1990;112(5):321–7. doi: 10.7326/0003-4819-112-5-321.
    1. MacDermid JC, Wessel J. Clinical diagnosis of carpal tunnel syndrome: a systematic review. J Hand Ther. 2004;17(2):309–20. doi: 10.1197/j.jht.2004.02.015.
    1. Middleton SD, Anakwe RE. Carpal tunnel syndrome. BMJ. 2014

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera